These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25888480)

  • 1. Validation of death prediction after breast cancer relapses using joint models.
    Mauguen A; Rachet B; Mathoulin-PĂ©lissier S; Lawrence GM; Siesling S; MacGrogan G; Laurent A; Rondeau V
    BMC Med Res Methodol; 2015 Apr; 15():27. PubMed ID: 25888480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort.
    Lafourcade A; His M; Baglietto L; Boutron-Ruault MC; Dossus L; Rondeau V
    BMC Cancer; 2018 Feb; 18(1):171. PubMed ID: 29426294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landmark risk prediction of residual life for breast cancer survival.
    Parast L; Cai T
    Stat Med; 2013 Sep; 32(20):3459-71. PubMed ID: 23494768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.
    Osmani F; Hajizadeh E; Rasekhi A; Akbari ME
    Breast; 2019 Dec; 48():82-88. PubMed ID: 31568898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of death risk of breast cancer patients with joint frailty models.
    Pasin O; Dirican A; Ankarali H; Disci R; Karanlik H
    Saudi Med J; 2020 May; 41(5):491-498. PubMed ID: 32373916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models.
    Mauguen A; Rachet B; Mathoulin-PĂ©lissier S; MacGrogan G; Laurent A; Rondeau V
    Stat Med; 2013 Dec; 32(30):5366-80. PubMed ID: 24030899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian approach for flexible modeling of semicompeting risks data.
    Han B; Yu M; Dignam JJ; Rathouz PJ
    Stat Med; 2014 Dec; 33(29):5111-25. PubMed ID: 25274445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation and prediction in a multi-state model for breast cancer.
    Putter H; van der Hage J; de Bock GH; Elgalta R; van de Velde CJ
    Biom J; 2006 Jun; 48(3):366-80. PubMed ID: 16845902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
    Wu X; Ye Y; Barcenas CH; Chow WH; Meng QH; Chavez-MacGregor M; Hildebrandt MA; Zhao H; Gu X; Deng Y; Wagar E; Esteva FJ; Tripathy D; Hortobagyi GN
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is the Effect of Using a Competing-risks Estimator when Predicting Survivorship After Joint Arthroplasty: A Comparison of Approaches to Survivorship Estimation in a Large Registry.
    Cuthbert AR; Graves SE; Giles LC; Glonek G; Pratt N
    Clin Orthop Relat Res; 2021 Feb; 479(2):392-403. PubMed ID: 33105301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint modelling of repeated transitions in follow-up data--a case study on breast cancer data.
    Genser B; Wernecke KD
    Biom J; 2005 Jun; 47(3):388-401. PubMed ID: 16053262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the long-term survival in breast cancer patients according to the present oncological status.
    Hatteville L; Mahe C; Hill C
    Stat Med; 2002 Aug; 21(16):2345-54. PubMed ID: 12210619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiple breast cancer stem cell model to predict recurrence of T
    Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
    BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer.
    Meier-Hirmer C; Schumacher M
    BMC Med Res Methodol; 2013 Jun; 13():80. PubMed ID: 23786493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritising deteriorating patients using time-to-event analysis: prediction model development and internal-external validation.
    Blythe R; Parsons R; Barnett AG; Cook D; McPhail SM; White NM
    Crit Care; 2024 Jul; 28(1):247. PubMed ID: 39020419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial.
    Finelli A; Beer TM; Chowdhury S; Evans CP; Fizazi K; Higano CS; Kim J; Martin L; Saad F; Saarela O
    JAMA Netw Open; 2021 Jun; 4(6):e2112426. PubMed ID: 34129025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
    Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
    Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study.
    Kwan ML; Kushi LH; Weltzien E; Tam EK; Castillo A; Sweeney C; Caan BJ
    J Clin Oncol; 2010 Oct; 28(29):4410-6. PubMed ID: 20805458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.